Literature DB >> 10825595

Intramuscular immunization with genetically inactivated (ghosts) Actinobacillus pleuropneumoniae serotype 9 protects pigs against homologous aerosol challenge and prevents carrier state.

A Hensel1, V Huter, A Katinger, P Raza, C Strnistschie, U Roesler, E Brand, W Lubitz.   

Abstract

Bacterial ghosts are empty cell envelopes achieved by the expression of a cloned bacteriophage lysis gene and, unlike classical bacterins, suffer no denaturing steps during their production. These properties may lead to a superior presentation of surface antigens to the immune system. Currently available porcine Actinobacillus pleuropneumoniae vaccines afford only minimal protection by decreasing mortality but not morbidity. Pigs which survive infection can still be carriers of the pathogen, so a herd once infected remains infected. Carrier pigs harbour A. pleuropneumoniae in their nasal cavities, in their tonsils, or within lung lesions. A dose-defined nose-only aerosol infection model for pigs was used to study the immunogenic and protective potential of systemic immunization with ghosts made from A. pleuropneumoniae serotype 9 reference strain CVI 13261 against an homologous aerogenous challenge. Pigs were vaccinated twice intramuscularly with a dose of 5x10(9) CFU ghosts (GVPs) or formalin-inactivated A. pleuropneumoniae bacterins (BVPs). After 2 weeks vaccinated pigs and non-vaccinated placebo controls (PCs) were challenged with a dose of 10(9) CFU by aerosol. The protective efficacy of immunization was evaluated by clinical, bacteriological, serological and post-mortem examinations. Bronchoalveolar lavage in pigs was performed during the experiment to obtain lavage samples (BALF) for assessment of local antibodies. Isotype-specific antibody responses in serum and BALF were determined by ELISAs based on whole-cell antigen. Immunization with ghosts did not cause clinical side-effects. After aerosol challenge PCs developed fever and pleuropneumonia. GVPs or BVPs were found to be fully protected against clinical disease or lung lesions in both vaccination groups, whereas colonization of the respiratory tract with A. pleuropneumoniae was only prevented in GVPs. Specific immunoglobins against A. pleuropneumoniae were not detectable in BALF after immunization. A significant systemic increase of IgM, IgA, IgG(Fc'), or IgG(H+L) antibodies reactive with A. pleuropneumoniae was measured in GVPs and BVPs when compared to the non-exposed controls. BVPs reached higher titers of IgG(Fc') and IgG(H+L) than GVPs. However, prevention of carrier state in GVPs coincided with a significant increase of serum IgA when compared to BVPs. These results suggest that immunization with ghosts, that bias antibody populations specific to non-denaturated surface antigens, may be more efficacious in protecting pigs against colonization and infection than bacterins.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10825595     DOI: 10.1016/s0264-410x(00)00107-9

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  20 in total

1.  Construction of an Actinobacillus pleuropneumoniae serotype 2 prototype live negative-marker vaccine.

Authors:  Walaiporn Tonpitak; Nina Baltes; Isabel Hennig-Pauka; Gerald F Gerlach
Journal:  Infect Immun       Date:  2002-12       Impact factor: 3.441

2.  Online monitoring of Escherichia coli ghost production.

Authors:  W Haidinger; M P Szostak; W Jechlinger; W Lubitz
Journal:  Appl Environ Microbiol       Date:  2003-01       Impact factor: 4.792

Review 3.  The Bacterial Ghost platform system: production and applications.

Authors:  Timo Langemann; Verena Juliana Koller; Abbas Muhammad; Pavol Kudela; Ulrike Beate Mayr; Werner Lubitz
Journal:  Bioeng Bugs       Date:  2010 Sep-Oct

4.  Protection of piglets by a Haemophilus parasuis ghost vaccine against homologous challenge.

Authors:  Mingming Hu; Yanhe Zhang; Fang Xie; Gang Li; Jianjun Li; Wei Si; Siguo Liu; Shouping Hu; Zhuo Zhang; Nan Shen; Chunlai Wang
Journal:  Clin Vaccine Immunol       Date:  2013-03-27

5.  Characterization of a novel inactivated Salmonella enterica serovar Enteritidis vaccine candidate generated using a modified cI857/λ PR/gene E expression system.

Authors:  Chetan V Jawale; Atul A Chaudhari; Byung Woo Jeon; Rahul M Nandre; John Hwa Lee
Journal:  Infect Immun       Date:  2012-01-30       Impact factor: 3.441

6.  A novel dual vector coexpressing PhiX174 lysis E gene and staphylococcal nuclease A gene on the basis of lambda promoter pR and pL, respectively.

Authors:  Lixia Fu; Chengping Lu
Journal:  Mol Biotechnol       Date:  2013-06       Impact factor: 2.695

7.  Field experience with two different vaccination strategies aiming to control infections with Actinobacillus pleuropneumoniae in a fattening pig herd.

Authors:  Marie Sjölund; Per Wallgren
Journal:  Acta Vet Scand       Date:  2010-03-25       Impact factor: 1.695

8.  Generation of Helicobacter pylori ghosts by PhiX protein E-mediated inactivation and their evaluation as vaccine candidates.

Authors:  Klaus Panthel; Wolfgang Jechlinger; Alexander Matis; Manfred Rohde; Michael Szostak; Werner Lubitz; Rainer Haas
Journal:  Infect Immun       Date:  2003-01       Impact factor: 3.441

9.  Escherichia coli ghost production by expression of lysis gene E and Staphylococcal nuclease.

Authors:  W Haidinger; U B Mayr; M P Szostak; S Resch; W Lubitz
Journal:  Appl Environ Microbiol       Date:  2003-10       Impact factor: 4.792

10.  Enhancement of bacteriolysis of shuffled phage PhiX174 gene E.

Authors:  Shen-ye Yu; Wei Peng; Wei Si; Lu Yin; Si-guo Liu; Hui-fang Liu; Hai-ling Zhao; Chun-lai Wang; Yue-hong Chang; Yue-zhi Lin
Journal:  Virol J       Date:  2011-05-06       Impact factor: 4.099

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.